Papers - YAMAMOTO Kenta
-
Gut microbes associated with functional cure of chronic hepatitis B Reviewed
Honda T, Ishigami M, Ishizu Y, Imai N, Ito T, Yamamoto K, Yokoyama S, Muto H, Inukai Y, Kato A, Murayama A, Yoshio S, Ishikawa T, Fujishiro M, Kawashima H, Kato T.
HEPATOLOGY INTERNATIONAL 2025.1
-
Monoclonal Antibody Against Mature Interleukin-18 Ameliorates Colitis in Mice and Improves Epithelial Barrier Function Reviewed
Ikegami S, Maeda K, Urano T, Mu J, Nakamura M, Yamamura T, Sawada T, Ishikawa E, Yamamoto K, Muto H, Oishi A, Iida T, Mizutani Y, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Ishigami M, Kawashima H.
Inflamm Bowel Dis Vol. 30 ( 8 ) page： 1353 - 1366. 2024.8
-
High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis Reviewed
Umemura M, Honda A, Yamashita M, Chida T, Noritake H, Yamamoto K, Honda T, Ichimura-Shimizu M, Tsuneyama K, Miyazaki T, Kurono N, Leung PSC, Gershwin ME, Suda T, Kawata K.
J Autoimmun Vol. 148 page： 103287 2024.7
-
Monoclonal Antibodies Against Mature Interleukin-18 Ameliorate Colitis and Repair Goblet Cell Function Reviewed
Mu J, Maeda K, Ohashi A, Urano T, Nariai Y, Kamino H, Nakamura M, Yamamura T, Sawada T, Ishikawa E, Murate K, Yamamoto K, Hirose T, Furukawa K, Fujishiro M, Kawashima H.
DIGESTIVE DISEASES AND SCIENCES Vol. 69 ( 7 ) page： 2573 - 2585 2024.7
-
Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma Reviewed
Inukai Y, Yamamoto K, Honda T, Yokoyama S, Ito T, Imai N, Ishizu Y, Nakamura M, Ishigami M, Kawashima H.
Cancers (Basel) Vol. 26 ( 9 ) page： 1675 2024.5
-
Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver Disease Reviewed
Yamamoto K, Honda T, Inukai Y, Yokoyama S, Ito T, Imai N, Ishizu Y, Nakamura M, Kawashima H.
Microorganisms Vol. 19 ( 3 ) page： 610 2024.3
-
Characteristics of microbiomes of the saliva, duodenal bulb, and descending portion of superficial nonampullary duodenal epithelial tumors Reviewed
Shibata H, Yamamoto K, Hirose T, Furune S, Kakushima N, Furukawa K, Nakamura M, Honda T, Fujishiro M, Kawashima H.
Dig Liver Dis Vol. 26 ( 24 ) page： 941 - 950 2024.2
-
Effects of 1-kestose on microbiome changes caused by vonoprazan: a randomized, double-blind, placebo-controlled pilot study Reviewed
Furune S, Suzuki T, Honda T, Yamamoto K, Furukawa K, Nakamura M, Ishigami M, Kinoshita F, Kadota Y, Tochio T, Shimomura Y, Hirooka Y, Fujishiro M, Kawashima H.
J Gastroenterol Hepatol Vol. 39 ( 3 ) page： 480 - 488 2023.12
-
Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis Reviewed
Sugiyama Y, Yamamoto K, Honda T, Kato A, Muto H, Yokoyama S, Ito T, Imai N, Ishizu Y, Nakamura M, Asano T, Enomoto A, Zaitsu K, Ishigami M, Fujishiro M, Kawashima H.
Hepatol Internatoinal Vol. 17 ( 6 ) page： 1378 - 1392 2023.9
-
Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study Reviewed
Ikegami S, Nakamura M, Honda T, Yamamura T, Maeda K, Sawada T, Ishikawa E, Yamamoto K, Furune S, Ishikawa T, Furukawa K, Ohno E, Ishigami M, Kinoshita F, Kadota Y, Tochio T, Shimomura Y, Hirooka Y, Kawashima H.
Aliment Pharmacol Ther Vol. 57 ( 11 ) page： 1249 - 1257 2023.1
-
Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma Reviewed
Inukai Y, Yamamoto K, Honda T, Ito T, Imai N, Ishizu Y, Nakamura M, Kawashima H, Ishigami M.
Vol. 41 ( 1 ) page： 138 - 147 2023
-
Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan Reviewed
Hamazaki M, Sawada T, Yamamura T, Maeda K, Mizutani Y, Ishikawa E, Furune S, Yamamoto K, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Nakamura M, Fujishiro M.
Vol. 22 ( 1 ) page： 342 - - 2022.7
-
Changes in the gut microbiome in relation to the degree of gastric mucosal atrophy before and after Helicobacter pylori eradication Reviewed
Furune S, Yamamoto K, Honda T, Fujiyoshi T, Kakushima N, Furukawa K, Ohno E, Nakamura M, Miyahara R, Kawashima H, Ishigami M, Hirooka Y, Fujishiro M.
Scand J Gastroenterol Vol. 57 ( 3 ) page： 266 - 273 2022.5
-
Patients with low muscle mass have characteristic microbiome with low potential for amino acid synthesis in chronic liver disease Reviewed
Yamamoto K, Ishizu Y, Honda T, Ito T, Imai N, Nakamura M, Kawashima H, Kitaura Y, Ishigami M, Fujishiro M.
Sci Rep Vol. 12 ( 1 ) page： 3674 2022.3
-
慢性肝疾患患者におけるサルコペニアと腸内細菌叢 Invited Reviewed
山本 健太, 石津 洋二, 本多 隆
Progress in Medicine Vol. 42 ( 3 ) page： 233 - 238 2022.3
-
Preliminary Comparison of Endoscopic Brush and Net Catheters as the Sampling Tool to Analyze the Intestinal Mucus in the Rectum with Ulcerative Colitis Patients Reviewed
Nakamura M, Maeda K, Yamamoto K, Yamamura T, Sawada T, Ishikawa E, Kakushima N, Furukawa K, Iida T, Mizutani Y, Ishikawa T, Ohno E, Honda T, Ishigami M, Kawashima H.
Digestion Vol. 103 ( 3 ) page： 232 - 243 2022.2
-
Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer Reviewed
Ohashi A, Yamamura T, Nakamura M, Maeda K, Sawada T, Ishikawa E, Yamamoto K, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Fujishiro M.
Vol. 103 ( 6 ) page： 451 - 461 2022
-
Changes in the gut microbiota after hepatitis C virus eradication Reviewed
Honda T, Ishigami M, Yamamoto K, Takeyama T, Ito T, Ishizu Y, Kuzuya T, Nakamura M, Kawashima H, Miyahara R, Ishikawa T, Hirooka Y, Fujishiro M.
Sci Rep Vol. 11 ( 1 ) page： 23568 2021.12
-
Measurement of fasting breath hydrogen concentration as a simple diagnostic method for pancreatic exocrine insufficiency Reviewed
Uetsuki K, Kawashima H, Ohno E, Ishikawa T, Iida T, Yamamoto K, Furukawa K, Nakamura M, Honda T, Ishigami M, Hirooka Y, Fujishiro M
BMC gastroenterology Vol. 21 ( 1 ) page： 211 2021.5
-
Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine Reviewed
Kenta Yamamoto Takashi Honda Shinya Yokoyama Lingyun Asuka Kato Takanori Ito Yoji Ishizu Teiji Kuzuya Masanao Nakamura Hiroki Kawashima Masatoshi Ishigami Noriko M.Tsuji Mitsuhiro Fujishiro
Digestive and Liver Disease Vol. 53 ( 11 ) page： 1443 - 1450 2021
-
Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis. Reviewed
Muto H, Ito T, Tanaka T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Maeda K, Honda T, Ishikawa T, Kato A, Ohshiro T, Kano F, Yamamoto A, Sakai K, Hibi H, Ishigami M, Fujishiro M
Scientific reports. Vol. 11 ( 1 ) page： 18778 2021
-
The microbiome can predict mucosal healing in small intestine in patients with Crohn’s disease Reviewed
Shun Hattori, Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Tsunaki Sawada, Yasuyuki Mizutani, Kenta Yamamoto, Takuya Ishikawa, Kazuhiro Furukawa, Eizaburo Ohno, Takashi Honda, Hiroki Kawashima, Masatoshi Ishigami, Yoshiki Hirooka Mitsuhiro Fujishiro
Journal of gastroenterology Vol. 55 ( 12 ) page： 1138 - 1149 2020.12
-
The relationship between oral-origin bacteria in the fecal microbiome and albumin-bilirubin grade in patients with hepatitis C Reviewed
Kenta Yamamoto , Takashi Honda , Takanori Ito , Yoji Ishizu , Teiji Kuzuya , Masanao Nakamura , Ryoji Miyahara , Hiroki Kawashima , Masatoshi Ishigami , Mitsuhiro Fujishiro
Journal of Gastroenterology and Hepatology Vol. 36 ( 3 ) page： 790 - 799 2020.8
-
Relationship between Adverse Events and Microbiomes in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Reviewed
Yamamoto, Kenta, Teiji Kuzuya, Takashi Honda, Takanori Ito, Yoji Ishizu, Masanao Nakamura, Ryoji Miyahara, Hiroki Kawashima, Masatoshi Ishigami, and Mitsuhiro Fujishiro
Anticancer Research Vol. 40 ( 2 ) page： 665–76 2020
-
Microbiota Profile Is Different for Early and Invasive Colorectal Cancer and Is Consistent throughout the Colon. Reviewed
Zorron Cheng Tao Pu, Leonardo, Kenta Yamamoto, Takashi Honda, Masanao Nakamura, Takeshi Yamamura, Shun Hattori, Alastair D. Burt, Rajvinder Singh, Yoshiki Hirooka, and Mitsuhiro Fujishiro.
Journal of Gastroenterology and Hepatology Vol. 35 ( 3 ) page： 433–37 2020
-
Influence of Proton Pump Inhibitors on Microbiota in Chronic Liver Disease Patients. Reviewed
Yamamoto, Kenta, Masatoshi Ishigami, Takashi Honda, Tomoaki Takeyama, Takanori Ito, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Hidemi Goto, and Yoshiki Hirooka.
Hepatology International Vol. 13 ( 2 ) page： 234–44 2019
-
Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitors Reviewed
Yasuda T, Ito T, Ishikawa T, Mizuno K, Yamamoto T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Koshiyama Y, Yasuda S, Toyoda H, Ando Y, Shimoyama Y, Kawashima H.
DIGESTIVE DISEASES AND SCIENCES Vol. 25 page： 38 - 6 2025.1
-
A Proposal for a Simple Subclassification of Advanced Hepatocellular Carcinoma in Systemic Treatment Reviewed
Imai N, Yamamoto T, Mizuno K, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Kawashima H.
Cancers Vol. 43 ( 8 ) page： 1855 - 1856 2024.11
-
Type 2 Diabetes and Hypertension as Risk Factors for Advanced Fibrosis in Biopsy Proven Metabolic Dysfunction-Associated Steatotic Liver Disease Reviewed
Inukai Y, Ito T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Shimizu T, Hattori M, Takeyama T, Ando Y, Nishikawa T, Morita K, Toyoda H, Ishigami M, Kawashima H.
Journal of Digestive Diseases Vol. 15 ( 11 ) page： 685 - 693 2024.11
-
Impact of BMI and Body Composition on First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma Reviewed
Yamamoto T, Ito T, Mizuno K, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H.
Anticancer Res Vol. 44 ( 9 ) page： 4101 - 4111 2024.8
-
Predicting early rebleeding and mortality after endoscopic hemostasis of esophagogastric varices: Diagnostic performance of aspartate aminotransferase-to-platelet ratio index and model for end-stage liver disease-Na score Reviewed
Yokoyama S, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Mizuno K, Nakamura M, Kawashima H.
J Hepatobiliary Pancreat Sci 2024.7
-
Clinical Outcomes of Use of the Porous Glass Membrane Pumping Emulsification Device During Transarterial Chemoembolization for Hepatocellular Carcinoma Reviewed
Mizuno F, Imai N, Mizuno K, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kawashima H.
Anticancer Res Vol. 44 ( 7 ) page： 3185 - 3191 2024.6
-
Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center Reviewed
Yokoyama S, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Mizuno K, Kojima T, Kariya N, Nakamura M, Kawashima H.
Clin Nutr Vol. 43 ( 6 ) page： 1425 - 1432 2024.5
-
Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team Reviewed
Ito T, Mizuno K, Yamamoto T, Yasuda T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Hama M, Kataoka T, Shimokata T, Ando Y, Kawashima H.
Hepatol Res 2024.4
-
A new criterion including the aspartate aminotransferase-to-platelet ratio index and liver and spleen stiffness to rule out varices needing treatment in children with biliary atresia: Modification of the Baveno VII criteria Reviewed
Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Muto H, Shirota C, Tainaka T, Sumida W, Makita S, Takada S, Nakagawa Y, Maeda T, Nakamura M, Ishigami M, Uchida H, Kawashima H.
Hepatol Res 2023.10
-
Clinical course and prognosis of patients with hepatocellular carcinoma and haemophilia Reviewed
Matsuda N, Imai N, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Kawashima H.
European Journal of Gastroenterology and Hepatology Vol. 35 ( 10 ) page： 1211 - 1215 2023.8
-
Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma Reviewed
Mizuno K, Imai N, Yamamoto T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kuzuya T, Ishigami M, Kawashima H.
Cancers Vol. 21 ( 15 ) page： 2853 2023.6
-
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis Reviewed
Yamamoto T, Mizuno K, Ito T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Ishikawa T, Kanamori A, Yasuda S, Toyoda H, Yokota K, Hase T, Nishio N, Maeda O, Ishii M, Sone M, Ando Y, Akiyama M, Ishigami M, Kawashima H.
Investigational New Drugs Vol. 41 ( 3 ) page： 512 - 521 2023.5
-
Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular Necrosis Reviewed
Mizuno F, Imai N, Yasuda K, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M, Kawashima H.
Internal Medicine 2023.5
-
Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases Reviewed
Imai N, Ohsaki Y, Cheng J, Zhang J, Mizuno F, Tanaka T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M, Wake H, Kawashima H.
Scientific Reports Vol. 26 ( 13 ) page： 6851 2023.4
-
腹部領域の技術と臨床の最新動向 放射線治療におけるMRI-US Fusion技術を活用した金マーカー留置の実際 Invited
山本 健太
INNERVISION Vol. 38 ( 5 ) page： 50 - 53 2023.4
-
Proteomic Analysis Reveals Changes in Tight Junctions in the Small Intestinal Epithelium of Mice Fed a High-Fat Diet Reviewed
Muto H, Honda T, Tanaka T, Yokoyama S, Yamamoto K, Ito T, Imai N, Ishizu Y, Maeda K, Ishikawa T, Adachi S, Sato C, Tsuji NM, Ishigami M, Fujishiro M, Kawashima H.
Nutrients Vol. 19 ( 15 ) page： 1473 2023.3
-
Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury Reviewed
Yamamoto T, Morooka H, Ito T, Ishigami M, Mizuno K, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Yokota K, Hase T, Maeda O, Hashimoto N, Ando Y, Akiyama M, Kawashima H.
Vol. 38 ( 2 ) page： 251 - 258 2023.2
-
Endoscopic injection sclerotherapy with polidocanol for cardiac varices in children and adolescents Reviewed
Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Hinoki A, Sumida W, Shirota C, Tainaka T, Makita S, Yokota K, Uchida H, Ishigami M.
Vol. 30 ( 2 ) page： 109 - 112 2023.2
-
Significance of pretreatment alpha-fetoprotein in patients with compensated severe fibrosis after hepatitis C viral eradication Reviewed
Ishigami M, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Kawashima H.
J Hepatobiliary Pancreat Sci Vol. 30 ( 6 ) page： 834 - 842 2023.1
-
Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet Reviewed
Zhao M, Ma L, Honda T, Kato A, Ohshiro T, Yokoyama S, Yamamoto K, Ito T, Imai N, Ishizu Y, Nakamura M, Kawashima H, Tsuji NM, Ishigami M, Fujishiro M.
Vol. 68 ( 1 ) page： 155 - 163 2023.1
-
The presence of high-risk varices after sclerotherapy in biliary atresia Reviewed
Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Shirota C, Tainaka T, Sumida W, Makita S, Takimoto A, Nakagawa Y, Takada S, Ishigami M, Uchida H, Kawashima H.
Pediatr Int Vol. - ( - ) page： - - - 2022.12
-
Pipeline Esophagogastric Varices Secondary to Extrahepatic Portal Vein Obstruction Treated Endoscopically with the Assistance of Transileocolic Obliteration Reviewed
Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Komada T, Hayashi M, Ishigami M.
Vol. 61 ( 23 ) page： 3503 - 3511 2022.12
-
Effect of illness uncertainty on alanine transaminase levels and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease Reviewed
Ozawa N, Sato K, Sugimura A, Maki S, Tanaka T, Yamamoto K, Ito T, Ishizu Y, Kuzuya T, Honda T, Ishigami M, Fujishiro M, Ishikawa T, Ando S.
Vol. 84 ( 4 ) page： 857 - 864 2022.11
-
Decreased appetite is associated with the presence of sarcopenia in patients with cirrhosis Reviewed
Ishizu Y, Ishigami M, Honda T, Imai N, Ito T, Yamamoto K, Yokoyama S, Ishikawa T, Kawashima H.
Nutrition Vol. - ( - ) page： - - - 2022.11
-
Factors associated with the progression of myosteatosis in patients with cirrhosis Reviewed
Ishizu Y, Ishigami M, Honda T, Imai N, Ito T, Yamamoto K, Yokoyama S, Ishikawa T, Fujishiro M.
Nutrition Vol. - ( - ) page： - - - 2022.11
-
An improved method to assess skeletal muscle mass in patients with liver cirrhosis based on computed tomography images Reviewed
Sugiyama Y, Ishizu Y, Ando Y, Yokoyama S, Yamamoto K, Ito T, Imai N, Nakamura M, Honda T, Kawashima H, Ishikawa T, Ishigami M.
Vol. 52 ( 11 ) page： 937 - 946 2022.11
-
Effectiveness of Porous Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Solitary Hepatocellular Carcinoma Reviewed
Imai N, Ishigami M, Oie Y, Kumagai M, Inukai Y, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Kawashima H.
Vol. 42 ( 8 ) page： 3947 - 3951 2022.8
-
A case of antiprogrammed death-ligand 1 antibody-induced multisystem immune-related adverse events with pancreatitis and steroid-resistant sclerosing cholangitis Reviewed
Yamamoto T, Ito T, Mizuno K, Shinya Y, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H, Matsui T, Hase T, Hashimoto N, Ishigami M.
Vol. 23 ( 7 ) page： 404 - 409 2022.7
-
Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study Reviewed
Yamamoto T, Imai N, Kuzuya T, Yokoyama S, Yamamoto K, Ito T, Ishizu Y, Honda T, Ishigami M.
Nutr Cancer Vol. 74 ( 9 ) page： 3118 - 3127 2022.3
-
Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors Reviewed
Yamamoto T, Ito T, Hase T, Ishigami M, Mizuno K, Yamamoto K, Imai N, Ishizu Y, Honda T, Shibata H, Hatta T, Yogo N, Yasuda S, Toyoda H, Abe T, Kawashima H, Hashimoto N, Fujishiro M.
Vol. 40 ( 2 ) page： 189 - 198 2022.2
-
Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis Reviewed
Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Tsuzuki T, Ishigami M.
Vol. 52 ( 2 ) page： 199 - 209 2022.2
-
Obesity and myosteatosis: the two characteristics of dynapenia in patients with cirrhosis Reviewed
Sugiyama Y, Ishizu Y, Ando Y, Yokoyama S, Yamamoto K, Ito T, Imai N, Nakamura M, Honda T, Kawashima H, Ishikawa T, Ishigami M.
Eur J Gastroenterol Hepatol Vol. 33 ( S1 ) page： :e916 - e921 2021.12
-
Safety and Efficacy of Glass Membrane Pumping Emulsification Device in Transarterial Chemoembolization for Hepatocellular Carcinoma: First Clinical Outcomes. Reviewed
Norihiro Imai, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami
Anticancer research Vol. 41 ( 11 ) page： 5817 - 5820 2021.11
-
Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis Reviewed
Shinya Yokoyama, Yoji Ishizu 1, Takashi Honda, Norihiro Imai, Takanori Ito, Kenta Yamamoto, Tomoyuki Tsuzuki, Masatoshi Ishigami
Hepatology research Vol. 52 ( 2 ) page： 199 - 209 2021.10
-
Immune-related liver injury is a poor prognostic factor in patients with non-small cell lung cancer treated with immune checkpoint inhibitors Reviewed
Takafumi Yamamoto, Takanori Ito, Tetsunari Hase, Masatoshi Ishigami, Kazuyuki Mizuno, Kenta Yamamoto, Norihiro Imai, Yoji Ishizu, Takashi Honda, Hirofumi Shibata, Takahiro Hatta, Naoyuki Yogo, Satoshi Yasuda, Hidenori Toyoda, Takashi Abe, Hiroki Kawashima, Naozumi Hashimoto, Mitsuhiro Fujishiro
Cancer investigation 2021.10
-
The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia: HCC after HCV eradication in hemophilia. Reviewed
Inukai Y, Imai N, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Fujishiro M
Annals of hepatology 2021.9
-
Revisiting Prognosis After Liver Transplant in Patients Positive for Hepatitis C Virus: Focus on Hepatitis C Recurrence-Unrelated Complications. Reviewed
Ishigami M, Honda T, Ishizu Y, Imai N, Ito T, Yamamoto K, Kamei H, Ogura Y, Fujishiro M
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation Vol. 19 ( 9 ) page： 935 - 942 2021.9
-
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies Reviewed
Ito T, Ishigami M, Yamamoto T, Mizuno K, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H, Yasuda S, Toyoda H, Yokota K, Hase T, Nishio N, Maeda O, Kato M, Hashimoto N, Hibi H, Kodera Y, Sone M, Ando Y, Akiyama M, Shimoyama Y, Fujishiro M
Hepatology international Vol. 15 ( 5 ) page： 1278 - 1287 2021.8
-
Quality of Life in patients with nonalcoholic fatty liver disease: Structure and related factors focusing on illness uncertainty. Reviewed
Naoki Ozawa Kazuki Sato Ayumi Sugimura Shigeyoshi Maki Taku Tanaka Kenta Yamamoto Takanori Ito Yoji Ishizu Teiji Kuzuya Takashi Honda Masatoshi Ishigami Mitsuhiro Fujishiro Tetsuya Ishikawa Shoko Ando
Japan journal of nursing science 2021.3
-
Progression After Molecular Targeted Agents: Hepatic Arterial Changes and Transarterial Chemoembolization in Hepatocellular Carcinoma Reviewed
NORITAKA MATSUDA, NORIHIRO IMAI, TEIJI KUZUYA, KENTA YAMAMOTO, TAKANORI ITO, YOJI ISHIZU, TAKASHI HONDA, MASATOSHI ISHIGAMI and MITSUHIRO FUJISHIRO
In vivo. Vol. 35 ( 2 ) page： 1185 - 1189 2021.3
-
Impact of visceral fat accumulation on the prognosis of patients with cirrhosis Reviewed
Yoji Ishizu Masatoshi Ishigami Takashi Honda Norihiro Imai Takanori Ito Kenta Yamamoto Mitsuhiro Fujishiro
Clinical Nutrition ESPEN 2021.1
-
Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma patients with haemophilia Reviewed
Takafumi Yamamoto Norihiro Imai Kenta Yamamoto Takanori Ito Yoji Ishizu Takashi Honda Shuichi Okamoto Takeshi Kanematsu Nobuaki Suzuki Tadashi Matsushita Masatoshi Ishigami Mitsuhiro Fujishiro
Haemophilia Vol. 27 ( 1 ) page： 100 - 107 2021.1
-
Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs Reviewed
Yamamoto T, Imai N, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Fujishiro M.
Anticancer research Vol. 40 ( 5 ) page： 2569 - 2573 2021
-
The albumin-bilirubin score as a predictor of outcomes in Japanese patients with PBC: an analysis using time-dependent ROC Reviewed
Ito T, Ishigami M, Morooka H, Yamamoto K, Imai N, Ishizu Y, Honda T,Nishimura D, Tada T, Yasuda S, Toyoda H, Kumada T, Fujishiro
Scientific reports. Vol. 10 ( 1 ) page： 17812 2020.10
-
Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice.
Ma, Lingyun, Masatoshi Ishigami, Takashi Honda, Shinya Yokoyama, Kenta Yamamoto, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Yoshiki Hirooka, and Hidemi Goto.
Digestive Diseases and Sciences Vol. 64 ( 9 ) page： 2581–90 2019
-
この症例に学ぶ 体外式腹部超音波検査にて描出しえた早期胃癌の一例 Invited Reviewed
山本 健太, 熊田 卓, 久永 康宏, 金森 明, 多田 俊史, 北畠 秀介, 曽根 康博
日本消化器がん検診学会雑誌 Vol. 52 ( 3 ) page： 387-392 2014.5
-
術中色素動注法が切除範囲決定に有用であった小腸angioectasiaの1例(原著論文/症例報告) Reviewed
山本 健太, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 多田 俊史, 北畠 秀介, 曽根 康博
日本消化器病学会雑誌 Vol. 111 ( 4 ) page： 773-778 2014.4
-
肝細胞癌と鑑別が困難であったreactive lymphoid hyperplasiaの1例 Reviewed
山本 健太, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 多田 俊史, 北畠 秀介, 長谷川 綾平, 伊藤 隆徳, 安藤 祐資, 颯田 祐介, 田中 達也, 曽根 康博, 福里 利夫
肝臓 Vol. 54 ( 11 ) page： 755-764 2013.11
-
腹腔鏡下胆嚢摘出術後13年目に生じた金属クリップを核とした胆管結石の1例 Reviewed
山本 健太, 金森 明, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 多田 俊史, 安東 直人, 新家 卓郎, 坂井 圭介, 安田 諭, 安藤 祐資, 木村 純, 曽根 康博, 熊田 卓
日本消化器内視鏡学会雑誌 Vol. 55 ( 5 ) page： 1667-1672 2013.5
-
Oral supplementation with branched-chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C-related cirrhosis: A propensity score analysis Reviewed
Toshifumi Tada Takashi Kumada Hidenori Toyoda Seiki Kiriyama Makoto Tanikawa Yasuhiro Hisanaga Akira Kanamori Shusuke Kitabatake Takuro Niinomi Takanori Ito Ryohei Hasegawa Yusuke Ando Kenta Yamamoto Tatsuya Tanaka
Hepatology research Vol. 44 ( 3 ) page： 288 - 295 2013.4
-
Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients Reviewed
Kumada T, Toyoda H, Tada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Niinomi T, Yasuda S, Andou Y, Yamamoto K, Tanaka J
Journal of Hepatology Vol. 58 ( 3 ) page： 427-33 2013
-
肝切除を基本とした肝細胞癌の治療戦略 Invited Reviewed
多田 俊史, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 新家 卓郎, 長谷川 綾平, 伊藤 隆徳, 安田 諭, 安藤 祐資, 山本 健太, 田中 達也
消化器内科 Vol. 55 ( 5 ) page： 612-616 2012.11
-
この画像から何が読めるか? 肝腫瘤(図説) Invited Reviewed
山本 健太, 熊田 卓, 豊田 秀徳, 多田 俊史
肝胆膵画像 Vol. 14 ( 6 ) page： 542-545 2012.9
-
B型肝炎に対する核酸アナログ投与例の長期予後 Invited Reviewed
多田 俊史, 熊田 卓, 桐山 勢生, 谷川 誠, 豊田 秀徳, 久永 康宏, 金森 明, 新家 卓郎, 安東 直人, 坂井 圭介, 安田 諭, 木村 純, 安藤 祐資, 山本 健太
消化器内科 Vol. 54 ( 5 ) page： 608-613 2012.5
-
FOLFIRI+Panitumumab療法中に発症した薬剤性肺障害に対してステロイド・パルス療法が奏効したS状結腸癌の1例 Reviewed
山本 健太, 加藤 俊夫, 進藤 丈, 安藤 守秀, 安部 崇, 白木 晶, 中島 治典, 雪田 洋介
癌と化学療法 Vol. 53 ( 3 ) page： 326-330 2011.9
-
肝発癌を視野に入れたB型肝炎の治療戦略 Invited Reviewed
坂井 圭介, 熊田 卓, 豊田 秀徳, 桐山 勢生, 谷川 誠, 久永 康宏, 金森 明, 多田 俊史, 新家 卓郎, 安東 直人, 安田 諭, 安藤 祐資, 山本 健太, 木村 純
消化器内科 Vol. 53 ( 3 ) page： 326-330 2011.9
-
特異な形態を示し経カテーテル的動脈塞栓術を施行した膵十二指腸動脈瘤破裂の1例 Reviewed
山本 健太, 熊田 卓, 桐山 勢生, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 多田 俊史, 荒川 恭宏, 藤森 将志, 新家 卓郎, 安東 直人
胆道 Vol. 24 ( 4 ) page： 603-610 2010.10
-
コイン型リチウム電池誤飲により食道潰瘍を来した2例 後遺症を残さなかった1例と後遺症を残した1例 Reviewed
山本 健太, 岩田 晶子, 都間 佑介, 田中 龍一, 山本 崇裕, 永田 智子, 伊藤 貴美子, 鹿野 博明, 中嶋 義記, 近藤 富雄
小児科臨床 Vol. 63 ( 7 ) page： 1667-1673 2010.7
-
造影超音波検査で特徴的な所見が得られた肝細胞腺腫の1例 Reviewed
山本 健太, 熊田 卓, 桐山 勢生, 曽根 康博, 谷川 誠, 久永 康宏, 豊田 秀徳, 金森 明, 渥美 裕之, 高木 万起子, 中野 聡, 荒川 恭宏, 藤森 将志, 高橋 健一, 竹島 賢治, 乙部 克彦
肝胆膵画像 Vol. 11 ( 5 ) page： 564-570 2009.9